Immunotherapy is the intentional modulation of the immune system to reach a specific therapeutic goal. Through enhancing or suppressing immune response, immunotherapeutic drugs can have a pronounced effect on disease activity within the body.
Including:tyrosine kinase inhibitors, GPCR inhibitors, receptor agonist, enzyme inhibitors, proteasome inhibitors, apoptosis pathway inhibitors
Including: immune cell depletion, cytokine neutralizer, bi-specific antibodies, tri-specific antibodies, immune oncology applications
Including: CAR-T cells, artificial APCs, lipid nanoparticles, AAV-based therapies
Working with Labcorp means working with a partner with extensive experience of running therapeutic immunology studies across all classes of drugs. We use this experience to design the correct set of assays for your program and can run assays in non-GLP or fully GLP formats.
Characterization of cell-based test articles is critical for obtaining regulatory approval for new cell therapy entities. In this rapidly evolving therapeutic field, characterization often needs to be more thorough than what is indicated in current advanced therapy guidance. Labcorp I&I has extensive experience characterizing cell-based therapeutics to ensure regulatory needs are met, including applying principals of strength, purity, concentration, identity, and stability to cell-based test articles.
